News

Press Releases

Filter

Display #

01/20/2010

Phase 2 trial of LX4211 demonstrates significant and rapid improvements in multiple parameters in type 2 diabetic patients

11/23/2009

Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009

11/12/2009

Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome

10/27/2009

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Third Quarter Financial Results

10/20/2009

Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2009 Financial Results on October 27, 2009

10/14/2009

Lexicon Announces Completion of Public Offering of Common Stock

10/08/2009

Lexicon Announces Pricing of Common Stock in Public Offering

10/07/2009

Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock

09/15/2009

Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients with Type 2 Diabetes

09/09/2009

Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference

«Start Prev12345678910Next End»

Page 7 of 41